1. Home
  2. EDRY vs MYO Comparison

EDRY vs MYO Comparison

Compare EDRY & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EuroDry Ltd.

EDRY

EuroDry Ltd.

N/A

Current Price

$60.79

Market Cap

72.8M

ML Signal

N/A

Logo Myomo Inc.

MYO

Myomo Inc.

N/A

Current Price

$1.40

Market Cap

63.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EDRY
MYO
Founded
2018
2004
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.8M
63.8M
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
EDRY
MYO
Price
$60.79
$1.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
★ $45.33
$4.64
AVG Volume (30 Days)
182.9K
★ 322.8K
Earning Date
11-12-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $1,000,000,000.00
Revenue This Year
$40.95
$11.43
Revenue Next Year
$8.53
$12.29
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 40814.79
52 Week Low
$11.95
$0.61
52 Week High
$73.07
$1.89

Technical Indicators

Market Signals
Indicator
EDRY
MYO
Relative Strength Index (RSI) 55.24 47.02
Support Level $17.86 $1.36
Resistance Level $73.07 $1.71
Average True Range (ATR) 6.40 0.12
MACD -0.46 -0.02
Stochastic Oscillator 50.24 17.50

Price Performance

Historical Comparison
EDRY
MYO

About EDRY EuroDry Ltd.

EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulk such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers. It operates under one operating and one reportable segment, that of operating dry bulk vessels.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.

Share on Social Networks: